Keywords

Cancer, Factorial structure, Patient-reported outcomes, Pediatric, PROMIS, Reliability and validity

 

Authors

  1. Liu, Yanyan PhD, RN
  2. Yuan, Changrong PhD, RN, FAAN
  3. Wang, Jichuan PhD
  4. Shen, Nanping PhD(c), RN
  5. Shen, Min BSN, RN
  6. Hinds, Pamela S. PhD, RN, FAAN

Abstract

Background: The Pediatric Patient-Reported Outcomes Measurement Information System (PROMIS) was developed to measure symptoms and functions of children with a variety of chronic diseases. As the Chinese version of pediatric PROMIS (C-Ped-PROMIS) measures was developed, the measurement properties of C-Ped-PROMIS have not been demonstrated.

 

Objective: The aim of this study was to examine the reliability, validity, and factorial structure of the C-Ped-PROMIS measures in children with cancer in China.

 

Methods: A total of 272 children and adolescents were recruited from 3 hospitals in China. The 8 C-Ped-PROMIS measures and Pediatric Quality of Life Inventory General Core Module and Cancer Module were administered in a cross-sectional design. Known-group validity, concurrent validity, and item and scale reliability of these 8 measures were examined by using SPSS 21.0, and factorial structures were tested by using confirmatory factor analysis with Mplus 7.1.

 

Results: All 8 C-Ped-PROMIS measures showed good known-group validity as hypothesized (P < .05) and good concurrent validity measured by significant correlations with the Pediatric Quality of Life Inventory General Core Module and Cancer Module; the correlation coefficients ranged from r = 0.519 to r = 0.655, except for peer relationship with r = 0.255 and r = 0.136, respectively. The Cronbach's [alpha] of C-Ped-PROMIS ranged from .758 to .910, and model-estimated scale reliabilities ranged from 0.740 to 0.905. The confirmatory factor analysis models of each measure fit data very well.

 

Conclusions: All 8 C-Ped-PROMIS measures have a valid factorial structure as theoretically defined with good reliability and validity.

 

Implications for Practice: The C-Ped-PROMIS can be readily used to measure symptoms and functions of children and adolescents with cancer in China.